[1] ROMERO V,AKPINAR H,ASSIMOS D G.Kidney stones:a global picture of prevalence,incidence,and associated risk factors[J].Rev Urol,2010,12(2-3):e86-96.
[2] SOROKIN I,MAMOULAKIS C,MIYAZAWA K,et al.Epidemiology of stone disease across the world[J].World J Urol,2017,35(9):1301-1320.
[3] BHANOT R,JONES P,SOMANI B.Minimally invasive surgery for the treatment of ureteric stones-state-of-the-art review[J].Res Rep Urol,2021,13:227-236.
[4] SAKHAEE K.Recent advances in the pathophysiology of nephrolithiasis[J].Kidney Int,2009,75(6):585-595.
[5] OZBEK E.Induction of oxidative stress in kidney[J].Int J Nephrol,2012,2012:465897.
[6] GUZEL A,YUNUSOGLU S,CALAPOGLU M,et al.Protective effects of quercetin on oxidative stress-induced tubular epithelial damage in the experimental rat hyperoxaluria model[J].Medicina,2021,57(6):566.
[7] HOSEINYNEJAD K,ALI MARD S,MANSOURI Z,et al.Efficacy of chlorogenic acid against ethylene glycol-induced renal stone model:the role of NFKB-RUNX2-AP1-OSTERIX signaling pathway[J].Tissue Cell,2022,79:101960.
[8] 刘文刚,张光远,黎明,等.CXCL1/2/10介导的免疫炎症与草酸钙结石形成的关系[J].东南大学学报(医学版),2022,41(3):402-407.
[9] AMMON H,WAHL M.Pharmacology of Curcuma longa[J].Planta Med,1991,57(1):1-7.
[10] 熊礼佳,刘慎微.姜黄素对2型糖尿病大鼠肾组织OPN/NF-κB途径的影响[J].现代医学,2008,36(1):15-19.
[11] GHODASARA J,PAWAR A,DESHMUKH C,et al.Inhibitory effect of rutin and curcumin on experimentally-induced calcium oxalate urolithiasis in rats[J].Pharmacognosy Res,2010,2(6):388-392.
[12] LI Y,ZHANG J,LIU H,et al.Curcumin ameliorates glyoxylate-induced calcium oxalate deposition and renal injuries in mice[J].Phytomedicine,2019,61:152861.
[13] KAHKHAIE K R,MIRHOSSEINI A,ALIABADI A,et al.Curcumin:a modulator of inflammatory signaling pathways in the immune system[J].Inflammopharmacology,2019,27(5):885-900.
[14] EVAN A P,WORCESTER E M,COE F L,et al.Mechanisms of human kidney stone formation[J].Urolithiasis,2015,43(1):19-32.
[15] 刘文刚,黎明,程祎,等.基于rno-miRNA-484/rno-miR-138-5p/CXCL1信号轴探讨茅岩莓多糖干预草酸钙结石形成的机制[J].现代医学,2022,50(10):1242-1247.
[16] DAUDON M,LETAVERNIER E,FROCHOT V,et al.Respective influence of calcium and oxalate urine concentration on the formation of calcium oxalate monohydrate or dihydrate crystals[J].Comptes Rendus Chim,2016,19(11-12):1504-1513.
[17] AGGARWAL B B,SUNG B.Pharmacological basis for the role of curcumin in chronic diseases:an age-old spice with modern targets[J].Trends Pharmacol Sci,2009,30(2):85-94.
[18] FU Y S,CHEN T H,WENG L,et al.Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential[J].Biomed Pharmacother,2021,141:111888.
[19] CUI X,LIN L,SUN X,et al.Curcumin protects against renal ischemia/reperfusion injury by regulating oxidative stress and inflammatory response[J].Evid Based Complement Alternat Med,2021,2021:8490772.
[20] LIU J L,PAN Y Y,CHEN O,et al.Curcumin inhibits MCF-7 cells by modulating the NF-κB signaling pathway[J].Oncol Lett,2017,14(5):5581-5584.
[21] LENARDO M J,BALTIMORE D.NF-κB:a pleiotropic mediator of inducible and tissue-specific gene control[J].Cell,1989,58(2):227-229.
[22] BORGOHAIN M P,LAHKAR M,AHMED S,et al.Small mol-ecule inhibiting nuclear factor-κB ameliorates oxidative stress and suppresses renal inflammation in early stage of alloxan-induced diabetic nephropathy in rat[J].Basic Clin Pharmacol Toxicol,2017,120(5):442-449.
[23] MING S,TIAN J,MA K,et al.Oxalate-induced apoptosis through ERS-ROS-NF-κB signalling pathway in renal tubular epithelial cell[J].Mol Med,2022,28(1):88.
[24] GUIJARRO C,EGIDO J.Transcription factor-κB(NF-κB) and renal disease[J].Kidney Int,2001,59(2):415-424.
[25] ZHANG H,SUN S C.NF-κB in inflammation and renal diseases[J].Cell Biosci,2015,5:63.
[26] SANZ A B,SANCHEZ-NIÑO M D,RAMOS A M,et al.NF-κB in renal inflammation[J].J Am Soc Nephrol,2010,21(8):1254-1262. |